The causes of increase and decrease in factor VIII (antigemofilnogo globulin A)
Last reviewed: 20.11.2021
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
About a third of the "carriers" of hemophilia A, the activity of factor VIII is 25 to 49%. In patients with mild form and "carriers" of hemophilia A, clinical manifestations of the disease occur only after injuries and surgical interventions.
The minimal hemostatic level of factor VIII activity in the blood for performing operations is 25%, with a lower content the risk of postoperative hemorrhage is extremely high. The minimum hemostatic level of factor VIII activity in the blood for stopping bleeding is 15-20%, with a lower content the stop of bleeding without the introduction of a factor VIII patient is impossible. With von Willebrand's disease, the minimum hemostatic level of factor VIII activity for stopping bleeding and for the operation is 25%.
With ICE-syndrome, beginning with the II stage, there is a distinct decrease in the activity of factor VIII due to consumption coagulopathy. Severe liver disease can lead to a decrease in the content of factor VIII in the blood. The content of factor VIII decreases with von Willebrand's disease, as well as in the presence of specific antibodies to factor VIII.
The activity of factor VIII is significantly increased after splenectomy.
In clinical practice it is very important to differentiate hemophilia and von Willebrand's disease.
Indicators of coagulogram in hemophilia and von Willebrand disease
|
Index |
Hemophilia |
Von Willebrand's Disease |
|
Blood clotting time |
Increased |
Norm |
|
Duration of bleeding |
Norm |
Increased |
|
Aggregation of platelets with ristocetin |
Norm |
Decreased |
|
Prothrombin time |
Norm |
Norm |
|
APTTV |
Increased |
Norm |
|
Thrombin time |
Norm |
Norm |
|
Fibrinogen |
Norm |
Norm |